BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38528610)

  • 1. Metastasis of serous ovarian carcinoma to the breast: a case report and review of the literature.
    DueƱo S; Stein R; Jamal M; Lewis G; Hew K
    J Med Case Rep; 2024 Mar; 18(1):127. PubMed ID: 38528610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentation.
    Musa A; Joiner M; Dzul S; Miller SR
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
    Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
    Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian carcinoma metastatic to the breast.
    Wadhwa J; Dawar R; Kumar L
    Clin Oncol (R Coll Radiol); 1999; 11(6):419-21. PubMed ID: 10663336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
    Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
    J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
    Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral breast metastasis of ovarian carcinoma.
    Dursun P; Yanik FB; Kuscu E; Gultekin M; Ayhan A
    Eur J Gynaecol Oncol; 2009; 30(1):9-12. PubMed ID: 19317248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary splenic metastasis of ovarian cancer.
    Furukawa N
    Arch Gynecol Obstet; 2007 Jun; 275(6):499-502. PubMed ID: 17096159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases.
    Parker RL; Clement PB; Chercover DJ; Sornarajah T; Gilks CB
    Int J Gynecol Pathol; 2004 Jul; 23(3):265-72. PubMed ID: 15213603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer.
    Qu H; Xia Y; Li X
    Curr Gene Ther; 2020; 20(4):313-320. PubMed ID: 32851960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
    Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
    Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late recurrence (after more than 20 years) of epithelial ovarian carcinoma: case report and literature review.
    Menczer J; Schreiber L; Peled O; Levy T
    Arch Gynecol Obstet; 2015 Jun; 291(6):1199-203. PubMed ID: 25524538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast-Report of two cases and literature review.
    Panse G; Bossuyt V; Ko CJ
    J Cutan Pathol; 2018 Mar; 45(3):234-239. PubMed ID: 29194708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
    Li S; Zhu Z
    J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study.
    Sugarbaker PH; Stuart OA
    Surg Oncol; 2020 Dec; 35():441-446. PubMed ID: 33039850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer.
    Otrock ZK; Seoud MA; Khalifeh MJ; Makarem JA; Shamseddine AI
    Int J Gynecol Cancer; 2006; 16(5):1933-5. PubMed ID: 17009994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.